Gefitinib Zentiva

Gefitinib Zentiva is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Zentiva is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC with specific genetic markers.

Common effects of Gefitinib Zentiva may include skin rash, diarrhea, and nausea. Some patients may also experience fatigue or loss of appetite. These effects can vary in severity and may not affect everyone who takes the medication. It's important to discuss any persistent or concerning symptoms with a healthcare provider.

Gefitinib Zentiva should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions or those taking other medications should consult their healthcare provider before starting Gefitinib Zentiva.

Gefitinib Zentiva may interact with other medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.